Steady-state Pharmacokinetics of Efavirenz (Sustiva/Stocrin) 400 mg Once Daily in the Presence of Rifampicin and Isoniazid (Rifinah or the Local Generics)
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Efavirenz (Primary) ; Emtricitabine; Isoniazid; Lamivudine; Rifampicin; Tenofovir; Zidovudine
- Indications HIV infections
- Focus Pharmacokinetics
- 20 Jun 2017 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 20 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jan 2018.
- 28 Dec 2016 Status changed from not yet recruiting to recruiting.